Translated automatically – community improvements welcome.
Milnacipran
Milnacipran is a selective serotonin-norepinephrine reuptake inhibitor primarily used for the treatment of depression and fibromyalgia. It works by inhibiting the reuptake of serotonin and norepinephrine in the central nervous system, which increases neurotransmitter availability. The substance has a moderate side effect profile and is often used in patients who do not respond adequately to other antidepressants.
Mechanism of Action
- NET inhibitor
- SERT inhibitor
Names / Identifiers
IUPAC: Milnacipran
Effects
Effects described from scientific sources. Individual experiences vary.
Dosage
Individual sensitivity varies. Not a dosage recommendation.
Duration
Risks & Warnings
Warnings
- Pregnancy
- Liver diseases
- Renal insufficiency
Known Risks
- medium
- Mögliche Nebenwirkungen umfassen Übelkeit, Schwindel und Schlaflosigkeit.
Safer Use
- Start at a low dose
- Regular medical monitoring
- Avoid alcohol
Harm reduction tips do not replace medical advice.
Known Interactions
- MAO inhibitors
- Serotonin reuptake inhibitors
- other antidepressants
This list is not exhaustive. Interactions can have unpredictable effects.
Legal Status
Not legal advice. Status may change.
Entdecken
Ähnliche Substanzen
Basierend auf Substanzklasse, Rezeptoren, Wirkmechanismen und Wirkprofil.